 Patients with such condition begin to rapidly lose their eyesight.Sometimes, the disease appears very rapidly, especially after cataract surgery procedures.A new treatment for this disease, as first reported by Kahook and colleagues, involves the use of a novel group of medications known as anti-VEGF agents.